DalsnaFinance › IPOs › Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on March 23, 2016, pricing at $15.00 a share.
| Ticker | CRVS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 23, 2016 |
| Offering price | $15.00 |
| Shares offered | 4,700,000 |
| Total raised | $71M |
Corvus Pharmaceuticals, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.